Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander G Allen

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Frontiers in Genome Editing|May 1, 2023
Assessment of anti-HIV-1 guide RNA efficacy in cells containing the viral target sequence, corresponding gRNA, and CRISPR/Cas9Alexander G Allen, Cheng-Han Chung, Stephen D Worrell, et al.
Molecular Therapy. Nucleic Acids|August 21, 2020
Safe CRISPR-Cas9 Inhibition of HIV-1 with High Specificity and Broad-Spectrum Activity by Targeting LTR NF-κB Binding SitesCheng-Han Chung, Alexander G Allen, Andrew J Atkins, et al.
AIDS Research and Human Retroviruses|July 4, 2018
Broad-Spectrum and Personalized Guide RNAs for CRISPR/Cas9 HIV-1 TherapeuticsWill Dampier, Neil T Sullivan, Joshua Chang Mell, et al.
Scientific Reports|November 21, 2019
Novel gRNA design pipeline to develop broad-spectrum CRISPR/Cas9 gRNAs for safe targeting of the HIV-1 quasispecies in patientsNeil T Sullivan, Will Dampier, Cheng-Han Chung, et al.
Nature Biotechnology|May 1, 2023
A highly efficient transgene knock-in technology in clinically relevant cell typesAlexander G Allen, Samia Q Khan, Carrie M Margulies, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Frontiers in Genome Editing|May 1, 2023
Assessment of anti-HIV-1 guide RNA efficacy in cells containing the viral target sequence, corresponding gRNA, and CRISPR/Cas9Alexander G Allen, Cheng-Han Chung, Stephen D Worrell, et al.
Molecular Therapy. Nucleic Acids|August 21, 2020
Safe CRISPR-Cas9 Inhibition of HIV-1 with High Specificity and Broad-Spectrum Activity by Targeting LTR NF-κB Binding SitesCheng-Han Chung, Alexander G Allen, Andrew J Atkins, et al.
AIDS Research and Human Retroviruses|July 4, 2018
Broad-Spectrum and Personalized Guide RNAs for CRISPR/Cas9 HIV-1 TherapeuticsWill Dampier, Neil T Sullivan, Joshua Chang Mell, et al.
Scientific Reports|November 21, 2019
Novel gRNA design pipeline to develop broad-spectrum CRISPR/Cas9 gRNAs for safe targeting of the HIV-1 quasispecies in patientsNeil T Sullivan, Will Dampier, Cheng-Han Chung, et al.
Nature Biotechnology|May 1, 2023
A highly efficient transgene knock-in technology in clinically relevant cell typesAlexander G Allen, Samia Q Khan, Carrie M Margulies, et al.
Pageof 2